Does today's communication from the FDA constitute
Post# of 150221
(Total Views: 581)
Posted On: 12/21/2021 12:06:47 PM
Does today's communication from the FDA constitute a more accepting posture towards Leronlimab and Cytodyn by the FDA?
Could this revised position of the FDA have anything to do with Janet Woodcock's departure?
Could this revised position of the FDA have anything to do with Janet Woodcock's departure?
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
The Lawman
style="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]
Scroll down for more posts ▼